Melatonin reduces oxidative neurotoxicity due to quinolinic acid: In vitro and in vivo findings

Neuropharmacology

Volumn 39, Issue 3, 2000, Pages 507-514

  Cabrera, Javier ^a,b   Reiter, Russel J ^a   Tan, Dun Xian ^a   Qi, Wenbo ^a   Sainz, Rosa M ^a   Mayo, Juan Carlos ^a   Garcia, Joaquin J ^a   Kim, Seok Joong ^a   El Sokkary, Gamal ^a  

^a Mays Cancer Center at UT Health San Antonio   (United States)

^b UNIVERSITY OF LAS PALMAS DE GRAN CANARIA   (Spain)

Author keywords

Brain; Free radicals; Lipid peroxidation; Melatonin; Neurotoxicity; Quinolinic acid

Indexed keywords

FREE RADICAL; MALONALDEHYDE; MELATONIN; QUINOLINIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN; BRAIN HOMOGENATE; CONTROLLED STUDY; IN VITRO STUDY; IN VIVO STUDY; LIPID PEROXIDATION; MALE; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; OXIDATION; PRIORITY JOURNAL; RAT;

ANIMALS; BRAIN; FREE RADICAL SCAVENGERS; LIPID PEROXIDATION; MALONDIALDEHYDE; MELATONIN; QUINOLINIC ACID; RATS;

EID: 0033978674     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0028-3908(99)00128-8     Document Type: Article

References (69)

1. Acuña Castroviejo D., Reiter R.J., Menendez-Pelaez A., Pablos M.I., Burgos A. Characterization of high-affinity melatonin binding sites in purified cell nuclei of rat liver. Journal of Pineal Research. 16:1994;100-112.
2. Antolin I., Rodriguez C., Sainz R.M., Mayo J.C., Uria H., Kotler M.L., Rodriguez-Colunga M.J., Tolivia D., Menendez-Pelaez A. Neurohormone melatonin prevents cell damage: effect on gene expression for antioxidant enzymes. FASEB Journal. 10:1996;882-890.
3. Bautista A.P., Spitzer J.J. Superoxide anion generation by in situ perfused rat liver: effect of in vivo endotoxin. American Journal of Physiology. 259:1990;G907-G912.
4. Barlow-Walden L.R., Reiter R.J., Abe M., Pablos M.I., Menendez-Pelaez A., Chen L.D., Poeggeler B. Melatonin stimulates brain glutathione peroxidase activity. Neurochemistry International. 26:1995;497-520.
5. Bettahi I., Guerrero J.M., Reiter R.J., Osuna C. Physiological concentrations of melatonin inhibit the norepinephrine-induced activation of prostaglandin E2 and cyclic AMP production in rat hypothalamus: a mechanism involving inhibition of nitric oxide synthase. Journal of Pineal Research. 25:1998;34-40.
6. Bonilla E., Tanji K., Hirano M., Vu T.H., DiiMauro S., Schon E.A. Mitochondrial involvement in Alzheimer's disease. Biochimica et Biophysica Acta. 1410:1999;171-182.
7. Bradford M. A rapid and sensitive method for quantification of protein utilizing the principle of protein dye binding. Annals of Biochemistry. 72:1976;171-178.
8. Brusco L.L., Marquez M., Cardinali D.P. Monozygotic twins with Alzheimer's disease treated with melatonin. Journal of Pineal Research. 25:1998;260-263.
9. Cagnoli C.M., Atabay C., Kharlamova H., Manev H. Melatonin protects neurons from singlet oxygen-induced apoptosis. Journal of Pineal Research. 18:1995;222-226.
10. Chuang J., Lin M.T. Pharmacological effects of melatonin treatment on both locomotor activity and brain serotonin release in rats. Journal of Pineal Research. 17:1994;11-16.
11. Costa E.J.X., Lopez R.H., Lamy-Freund M.T. Permeability of pure lipid bilayers to melatonin. Journal of Pineal Research. 19:1995;123-126.
12. Cuzzocrea S., Zigarelli B., Gilad E., Hake P., Salzman A.L., Szabo C. Protective effect of melatonin in carrageenan-induced models of local inflammation. Journal of Pineal Research. 23:1997;106-166.
13. Garcia J.J., Reiter R.J., Ortiz G.G., Oh C.S., Tang L., Yu B.P., Escames G. Melatonin enhances tamoxifen's ability to prevent the reduction in microsomal membrane fluidity induced by lipid peroxidation. Journal of Membrane Biology. 162:1998;59-65.
14. Gilad E., Cuzzocrea S., Zigarelli B., Salzman A.L., Szabo C. Melatonin is a scavenger of peroxynitrite. Life Science. 60:1997;169-174.
15. Giusti P., Giusella M., Lipartiti M., Milani D., Zhu W., Vicini S., Manev H. Melatonin protects primary cultures of cerebellar granule neurons from kainate but not from N-Methyl-D-aspartete excitotoxicity. Experimental Neurology. 131:1995;39-46.
16. Götz M.E., Khnig G., Riederer P., Youdim M.B.H. Oxidative stress: free radical production in neuronal degeneration. Pharmacological Therapy. 63:1994;37-122.
17. Heyes M.P., Wyler A., Devinsky O., Markey S., Nadi S. Quinolinic concentration in brain and cerebrospinal fluid of patients with intractable complex partial seizures. Epilepsia. 29:1990;523-529.
18. Heyes M.P., Saito K., Crowley J.S., Davis L.E., Demitrack M.A., Der M., Dilling L.A., Elia J., Kruesi M.J.P., Lackner A., Larsen S.A., Lee K., Leonard H.L., Markey S.P., Martin A., Milstein S., Mouradian M.M., Pranzatell M.R., Quearry B.J., Salazar A., Smith M., Strauss S.E., Sunderland T., Swedo S.W., Tourtellotte W.W. Quinolinic acid and kynurenine pathway metabolism in inflammatory and non-inflammatory neurological disease. Brain. 115:1992;1249-1273.
19. Heyes M.P. The kynurenine pathway and neurological disease. Therapeutic strategies. Advances in Experimental Medicine and Biology. 398:1996;125-129.
20. Holson R.R. Euthanasia by decapitation: evidence that this technique produces prompt, painless unconsciousness in laboratory rodents. Neurotoxicological Teratology. 14:1992;253-257.
21. Joo J.-Y., Uz T., Manev H. Opposite effects of pinealectomy and melatonin administration on brain damage following cerebral focal ischemia in rat. Restorative Neurology and Neuroscience. 13:1998;185-191.
22. Kashii S., Mandai M., Kikuchi M., Honda Y., Tamura Y., Kaneda K., Akaike A. Dual actions of nitric oxide in N-methyl-D-aspartate receptor mediated neurotoxicity in cultured retinal neurons. Brain Research. 711:1996;93-101.
23. Kedziora J., Bartosz G. Down's syndrome: a pathology involving the lack of balance of reactive oxygen species. Free Radical Biology and Medicine. 4:1988;317-330.
24. Kennaway D.J., Royles P., Webb H., Carbomne F. Effects of protein restriction, melatonin administration and short daylength on brain benzodiazepine receptor in prepubertal male rats. Journal of Pineal Research. 5:1988;455-467.
25. Lapin I.P. Convulsions and tremor in immature rats after intraperitoneal injection of kynurenine and its metabolites. Pharmacological Research Communications. 10:1978;81-84.
26. Lapin I.P. Kynurenines and seizures. Epilepsia. 22:1981;257-265.
27. Lapin I.P., Mirzaev S.M., Rysov I.V., Oxenkrug G.F. Anticonvulsant activity of melatonin against seizures induced by quinolate, kainate, glutamate, NMDA, and pentylenetetrazole in mice. Journal of Pineal Research. 24:1998;215-218.
28. Lipton S.A., Choi Y.B., Pan Z.H., Lei S.Z., Chen H.S.V., Sucher N.J., Loscalzo J., Singel D.J., Stamler J.S. A redox-based mechanism for the neurodestructive effects of nitric oxide and related nitroso-compounds. Nature. 364:1993;626-632.
29. Manev H., Uz T., Kharlamov A., Joo J.Y. Increased brain damage after stroke or exitotoxic seizures in melatonin deficient rats. FASEB Journal. 10:1996;1546-1551.
30. Melchiorri D., Reiter R.J., Sewerynek E., Chen L.D., Nistico G. Melatonin reduces kainate-induced lipid peroxidation of different brain regions. FASEB Journal. 9:1995;1205-1210.
31. Menendez-Pelaez A., Poeggeler B., Reiter R.J., Barlow-Walden L., Pablos M.I., Tan D.-X. Nuclear localization of melatonin in different mammalian tissues: immunocytochemical and radioimmunoassay evidence. Journal of Cellular Biochemistry. 53:1993;373-382.
32. Mesenge C., Margaill I., Verrechia C., Allix M., Boula R.G., Plotkine M. Protective effect of melatonin in a model of traumatic brain injury in mice. Journal of Pineal Research. 25:1998;41-46.
33. Morgan D.J., Williams L.M. Central melatonin receptors: implication for a mode of action. Experientia. 45:1989;955-965.
34. Moroni F., Lombardi G., Carla V., Pellegrini D., Carassale G.L., Cortesini C. Content of quinolinic acid and of other tryptophan metabolites increase in brain regions of rats used as experimental models of hepatic encephalopathy. Journal of Neurochemistry. 46:1986;869-874.
35. Noda, Y., Mori, A., Liburty, R., Packer, L., 1999. Melatonin and its precursors scavenge nitric oxide. Journal of Pineal Research (in press).
36. Norlund J.J., Lerner A.B. The effects of oral melatonin on skin color and on the release of pituitary hormones. Journal of Clinical Endocrinology and Metabolism. 45:1977;768-774.
37. Okatani Y., Okamoto K., Hayashi K., Wakatsuki A., Tamura S., Sogara Y. Maternal-fetal transfer of melatonin in pregnant women near term. Journal of Pineal Research. 25:1998;129-134.
38. Pappolla M.A., Sos M., Omar R.A., Bick R.J., Hickson-Bick D.L., Reiter R.J., Efthimiopoulos S., Robakis N.K. Melatonin prevents death of neuroblastoma cells exposed to the Alzheimer amyloid peptide. Journal of Neuroscience. 17:1997;1683-1690.
39. Pierrefiche G., Laborit H. Oxygen free radicals, melatonin and aging. Experimental Gerontology. 30:1995;213-227.
40. Pozo D., Reiter R.J., Calvo J.R., Guerrero J.M. Inhibition of cerebellar nitric oxide synthase and cyclic GMP production by melatonin via complex formation with calmodulin. Journal of Cellular Biochemistry. 65:1997;430-442.
41. Princ F.G., Juknat A.A., Maxit A.G., Cardalda C., Batlle A. Melatonin's antioxidant protection against δ-aminolevulinic acid-induced oxidative damage in rat cerebellum. Journal of Pineal Research. 23:1997;40-46.
42. Reiter R.J. Pineal melatonin: cell biology of its synthesis and of its physiological interactions. Endocrine Reviews. 12:1991;151-160.
43. Reiter R.J. Oxidative processes and antioxidative defense mechanisms in the aging brain. FASEB Journal. 9:1995;526-533.
44. Reiter R.J. Aging and oxygen toxicity: relation to changes in melatonin. Annals of the New York Acadamy of Science. 20:1997;201-213.
45. Reiter R.J. Oxidative damage in the central nervous system: protection by melatonin. Progress in Neurobiology. 56:1998;359-384.
46. Reiter R.J., Garcia J.J., Pie J. Oxidative toxicity in models of neurodegeneration: responses to melatonin. Restorative Neurology and Neuroscience. 12:1998;135-142.
47. Rios C., Santamaria A. Quinolinic acid is a potent lipid peroxidant in rat brain homogenates. Neurochemical Research. 16:1991;1139-1143.
48. Rodriguez A.B., Nogales G., Barringa C. Melatonin controls superoxide anion level: Modulation of superoxide dismutase activity in ring dove heterophils. Journal of Pineal Research. 24:1998;9-14.
49. Santamaria A., Rios C. MK-801 an N-methyl-D-aspartate receptor antagonist, block quinolinic acid-induced lipid peroxidation in rat corpus striatum. Neuroscience Letters. 159:1993;51-54.
50. Santamaria A., Santamaria D., Diaz-Muûoz M., Espinoza-Gonzalez V., Rios C. Effects of NT-nitro-L-arginine and L-arginine on quinolinic acid-induced lipid peroxidation. Toxicology Letters. 93:1997;117-124.
51. Schapira A.H.V. Mitochondrial involvement in Parkinson's disease, Huntington's disease, hereditary spastic paraplejia and Friedreich's ataxia. Biochimica et Biophysica Acta. 1410:1999;159-170.
52. Schwarcz R., Köler C. Differential vulnerability of central neurons of the rat to quinolinic acid. Neuroscience Letters. 38:1983;85-90.
53. Schwarz R., Okuno E., White R.J., Bird E.D., Whetsell W.O. Jr. 3-Hydroxyantranilate oxygenase activity is increased in the brain of Huntington disease victims. Proceedings of the National Acadamy of Sciences USA. 85:1988;4079-4081.
54. Shida C.S., Castrucci A.M.L., Lamy-Freund M.T. High melatonin solubility in aqueous medium. Journal of Pineal Research. 16:1994;198-201.
55. Shuter S.L., Davies M.J., Garlick P.B., Hearse D.J., Slater T.F. Studies on the effects of antioxidants and inhibitors of radical generation on free radical production in the reperfused rat heart using electron spin resonance spectroscopy. Free Radical Research Communications. 9:1990;223-232.
56. Sies H., Sharov V.S., Klotz L.O., Briviba K. Glutathione peroxidase protects against peroxynitrite-mediated oxidations. Journal of Biological Chemistry. 272:1997;27812-27817.
57. Simonian N.A., Coyle J.T. Oxidative stress in neurodegenerative diseases. Annual Review of Pharmacology and Toxicology. 36:1996;83-106.
58. Southgate G.S., Daya S., Potgieter B. Melatonin plays a protective role in quinolinic acid-induced neurotoxicity in the rat hippocampus. Journal of Chemical Neuroanatomy. 14:1998;141-146.
59. Stasica P., Ulanski P., Rosiak J.M. Melatonin as a hydroxyl radical scavenger. Journal of Pineal Research. 25:1998;65-66.
60. Stone T.W. Neuropharmacology of quinolinic and kynurenic acids. Pharmacology Reviews. 45:1993;309.
61. Stone T.W., Perkins M.N. Quinolinic acid: A potent endogenous excitant amino acid receptors in CNS. European Journal of Pharmacology. 72:1981;411-412.
62. Tan D.-X., Chen L.-D., Poeggeler B., Manchester L.C., Reiter R.J. Melatonin: A potent, endogenous hydroxyl radical scavenger. Endocrine Journal. 1:1993;57-60.
63. Tan D.-X., Manchester L.C., Reiter R.J., Wenbo Q., Kim S.J., El-Sokkary G.H. Melatonin protects hippocampal neurons in vivo against kainic acid-induced damage in mice. Journal of Neuroscience Research. 54:1998;382-389.
64. Tan D.-X., Manchester L.C., Reiter R.J., Plummer B.F., Hardies L.J., Weintraub S.T., Vijayalaxmi Shepherd A.M.M. A novel melatonin metabolite, cyclic 3-hydroxymelatonin: A biomarker of in vivo hydroxyl radical generation. Biochemical and Biophysical Research Communucation. 253:1998;614-620.
65. Uz T., Giusti P., Franceschini D., Kharlamov A., Manev H. Protective effect of melatonin against hippocampal DNA damage induced by intraperitoneal administration of kainate to rats. Neuroscience. 74:1996;631-636.
66. Wolfensberger M., Amsler U., Cuenod M., Foster A.C., Whetsell W.O. Jr., Schwarcz R. Identifications of quinolinic acid in rat and human brain tissue. Neuroscience Letters. 41:1983;247-252.
67. Yamamoto H.A., Tang H.W. Antagonistic effect of melatonin against cyanide-induced seizures and acute lethality in mice. Toxicology Letters. 87:1996;19-24.
68. Yamamoto H.A., Tang H.W. Melatonin attenuates L-cysteine-induced seizures and lipid peroxidation in the brain of mice. Journal of Pineal Research. 21:1996;108-113.
69. Yoshikawa Y., Takano H., Takahashi S., Ichikawa H., Kondo M. Changes in tissue antioxidant enzyme activities and lipid peroxides in endotoxin-induced multiple organ failure. Cirulatory Shock. 42:1994;53-58.